Climb Bio Debt-to-Equity Ratio Growth & History (CLYM)

Climb Bio's debt-to-equity ratio was 0.00 for fiscal 2025.

View full Climb Bio company overview

Climb Bio annual debt-to-equity ratio history

Climb Bio annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.000.00+34.27%
20242024-12-310.00−0.00−22.59%
20232023-12-310.00−0.00−13.02%
20222022-12-310.000.00
20212021-12-310.00

Climb Bio debt-to-equity ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Climb Bio's debt-to-equity ratio increased from 0.00 to 0.00, a change of 0.00. The latest reported quarter, Q2 2026, shows 0.01.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Climb Bio source filings ↗

Community posts

It’s quiet here.

No posts about CLYM yet. Start the conversation.

Write the first post